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TRANSPORT OF PROTEINS INTO MITOCHONDRIA: 
RECEPTORS, RECOGNITION AND TRANSMEMBRANE MOVEMENT OF PRECURSORS 
B. SCHMIDT, R. PFALLER, N. PFANNER, M. SCHLEYER and W. NEUPERT, I n s t i t u t für 
Physiologische Chemie, Univers i t y of Munich, Goethestr. 33, 8000 München 2, FRG 
INTR0DUCTI0N 
Most of the mitochondrial proteins are coded f o r by nuclear genes, they are 
synthesized in the cytoplasm of the c e l l as precursor proteins and are then 
s e l e c t i v e l y imported by the mitochondria (1,2). The ov e r a l l import appears to 
consist of a number of d i s t i n c t sequential processes. The precursor proteins, 
most of which bear aminoterminal peptide extensions, bind to the mitochondrial 
surface and are then incorporated into the organelle. This transfer i s 
i r r e v e r s i b l e and i n most instances i s dependent on an energized mitochondrial 
inner membrane. The next step in the assembly pathway i s a processing reaction 
i. e . removal of the a d d i t i o n a l sequences and/or covalent modifications such as 
the attachment of heme in the case of cytochromes c and Cy 
F i n a l l y , the newly imported proteins reach t h e i r functional location and are 
assembled into a c t i v e complexes. 
Although we can d i s t i n g u i s h individual steps of the import reaction, l i t t l e 
i s known about the components (apart from the precursor proteins) that 
p a r t i c i p a t e in these reactions. In order to understand the molecular basis of 
import e f f o r t s are being made to define and characterize the components 
involved. 
In t h i s communication we describe experiments designed to elucidate the 
molecular mechanism of two aspects of protein transfer into mitochondria, v i z . 
binding of the precursor proteins to the mitochondria, and t h e i r subsequent 
transmembrane movement or membrane i n s e r t i o n . The components responsible f o r 
binding, i . e . receptors, are proteins located on the surface of the 
mitochondria. Translocation d i r e c t l y from the binding Sites i s very rapid. On 
the other hand we demonstrate the existence of transmembrane intermediates, 
i.e. precursor proteins which are pa r t l y imported and span both inner and outer 
mitochondrial membranes. We propose an import pathway f o r inner membrane and 
matrix proteins v i a contact Sites between inner and outer membrane. 
MATERIALS AND METHODS 
Estabiished procedures were used to study import of proteins into 
mitochondria employing in vitro synthesized precursor proteins and isolated 




Binding of precursor proteins to mitochondria 
The i n i t i a l Step in the import pathway subsequent to synthesis i s the binding 
of the precursor to the mitochondria. Binding was usually observed in a 
reconstituted in vitro System when import was i n h i b i t e d . This condition was 
achieved by destroying the membrane potential (e.g. f o r ADP/ATP c a r r i e r ) , by 
lowering the temperature (e.g. for porin) or by competitively i n h i b i t i n g a 
processing step (e.g. f o r cytochrome c) (6-8). In the case of the above 
mentioned proteins, i t was found that the binding Sites (although probably 
d i s t i n c t from each other) have common features: ( i ) they are saturable, ( i i ) 
they bind with high a f f i n i t y , ( i i i ) they appear to be proteins (Fig.1). The 
binding Sites for porin (see Fig. 2) and ADP/ATP c a r r i e r appear to be located 
on the mitochondrial surface (6), whereas the apocytochrome c binding 
protein i s located in the intermembrane space (9). The d i f f e r e n t location of 
these binding Sites i s also r e f l e c t e d by the d i f f e r e n t i a l s e n s i t i v i t y to 
bound precursor [cpm] 
Fig. 1. High affinity binding of the precursor to the ADP/ATP carrier is 
mediated by proteinaceous receptors. 
The precursor to ADP/ATP c a r r i e r was synthesized in a c e l l free System and 
p a r t i a l l y p u r i f i e d by ammcnium sul f a t e p r e c i p i t a t i o n . Mitochondria were 
incubated with various concentrations of precursor under conditions where only 
binding takes place and subsequently r e i s o l a t e d . ADP/ATP c a r r i e r was 
immunoprecipitated from the supernatants and mitochondrial p e l l e t s . 
Quantification of the r a d i o a c t i v i t y associated with the c a r r i e r was carried out 
af t e r excision of the c a r r i e r bands from an SDS ge l . The amount of c a r r i e r 
bound to mitochondria i s plotted versus the r a t i o bound/free (free = c a r r i e r 
recovered from the supernatants). Assuming a s p e c i f i c r a d i o a c t i v i t y of 
3x10 cpm/pmol ADP/ATP c a r r i e r the number of binding Sites was 1.7 pmol/mg 
mitochondrial protein and the K was 1.1x10 M . 
+ t r y p s i n : mitochondria were t r l a t e d with 5 ug of t r y p s i n per/mg mitochondrial 
protein p r i o r to the binding assay; - t r y p s i n : untreated mitochondria. 
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Fig. 2 . Binding of water-soluble porin to isolated mitochondria. 
Binding of porin to i t s receptor was studied in a s i m p l i f i e d assay System, in 
which isolated mitochondria and a water-soluble form of mitochondrial porin 
were incubated in buffer. The water-soluble porin was prepared from porin 
isolated from mitochondria with detergents, by removal of detergent and l i p i d s 
and by controlled denaturation and renaturation (7). The water-soluble form 
acquired a number of properties of the membrane form a f t e r i n s e r t i o n into 
a r t i f i c i a l l i p i d b i l a y e r s . After radioactive l a b e l l i n g by reductive methylation 
t h i s water-soluble porin was employed to measure s p e c i f i c receptor Sites on 
mitochondria. 
A mitochondrial preparation (2 mg protein) in 1 ml 0.25 M sucrose, 10 mM 
Tris-HCl, 1 nrM EDTA, pH 7.2 (SET) was divided into two halves. To one half 
100 Mg t r y p s i n i n h i b i t o r was added together with 5 ug t r y p s i n and 
incubation performed f o r 15 min at 25 °C. To the second half f i r s t 5 ug 
tr y p s i n were added, the sample was incubated for 15 min at 25 °C and then 
100 ug t r y p s i n i n h i b i t o r were added. Both samples were incubated f o r 3 min 
at 25 °C and then for 10 min at 0 °C. Mitochondria were r e - i s o l a t e d , washed 
once in SET containing 100 ug/ml soybean t r y p s i n i n h i b i t o r and resuspended 
in SET at a f i n a l concentration of 2 mg/ml. Binding of water-soluble porin 
to mitochondria was determined in samples which were prepared by mixing 125 
Ml r e t i c u l o c y t e lysate, 125 ul SET and 18 ul 0.1 M NaP., pH 6.8, 
containing 22 pmol water-soluble porin l a b e l l e d with C by reductive 
methylation ( s p e c i f i c r a d i o a c t i v i t y 82 uCi/Mmol). Three d i f f e r e n t amounts 
of mitochondria were employed: 2,3 : 50 Mg; 5,6 : 100 Mg; 8,9 : 250 Mg. 
Samples 1, 4 and 7 did not contain mitochondria and served to control 
binding to tube walls. Samples 2, 5 and 8 contained mitochondria pretreated 
with t r y p s i n . Samples 3, 6 and 9 contained mitochondria pretreated with 
trypsin in the presence of t r y p s i n i n h i b i t o r . A fter incubation for 20 min 
at 25 °C samples were centrifuged, the p e l l e t s resuspended, transferred to 
new tubes and centrifuged again. A l l were then dissolved in SDS containing 
buffer and subjected to gel electrophoresis. The dried gel was 
f luorographed. 
proteases. It i s reasonable to conclude that d i f f e r e n t types of interaction 
between precursor and receptor may e x i s t depending on the structure and the 
location of the receptor. 
That the receptor bound State i s a true intermediate State in the assembly 
pathway has been shown by the fact that bound precursors can be d i r e c t l y 
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imported from the binding S i tes . This import i s e f f i c i e n t and rapid.In the case 
of the ADP/ATP c a r r i e r the import i s 20-30 times f a s t e r than the observed 
import of the free precursor (Fig.3) The receptors i d e n t i f i e d appear to be 
essential components of the import pathway and represent the i n i t i a l mediators 
of the o v e r a l l process. 
1 2 3 4 5 6 7 8 9 10 
4 0 1 2 4 4 0 1 2 4 
Time of Incubat ion (min) 
Fig. 3. Kinetics of import of ADP/ATP carrier from receptor-bound State. 
Mitochondria were allowed to bind the precursor to the ADP/ATP c a r r i e r in the 
absence of a membrane potential (lanes 2-5, 7-10). As a c o n t r o l , import was 
allowed in lanes 1 and 6. After t h i s f i r s t incubation mitochondria were 
rei s o l a t e d and resuspended in fresh medium containing no precursors. The 
membrane potential was reestablished and import allowed f o r the indicated 
times. Then the samples were halved and e i t h e r the ADP/ATP c a r r i e r d i r e c t l y 
immunoprecipitated (lanes 1-5) or assayed f o r assembled c a r r i e r as described in 
ref . 5 (lanes 6-10). The immunoprecipitates were resolved on SDS-PAGE and the 
gel was fluorographed. 
Translocation of precursor proteins across mitochondrial membranes 
We have also studied the translocation of precursors across the mitochondrial 
membranes, in p a r t i c u l a r the movement of proteins destined f o r the inner 
membrane and the matrix. This step requires an energized mitochondrial inner 
membrane. Recent studies have revealed that the import of ADP/ATP c a r r i e r into 
the inner membrane can be driven by a valinomycin mediated K + d i f f u s i o n 
potential (Fig.4). This import cannot be abolished by addition of a 
protonophore. Furthermore, creation of a pH gradient does not stimulate import. 
These findings suggest that the membrane potential&\Jrper se and not the t o t a l 
protonmotive force Ap (with the components A^rarid apH) i s the d r i v i n g force 
f o r import (10). The molecular mechanism of the import, however, i s s t i l l 
enigmatic and l i t t l e i s known at the moment about the putative constituents of 
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Fig. 4. Import of ADP/ATP carrier driven by a K diffusion potential. 
The precursor to ADP/ATP c a r r i e r was bound to mitochondria i n the absence of a 
membrane p o t e n t i a l . Mitochondria were re i s o l a t e d and resuspended in fresh 
rredium containing valinomycin and the indicated concentrations of KCl. After 
incubation, samples were treated with Proteinase K to assay f o r imported 
c a r r i e r which was then immunoprecipitated. The immunoprecipitates were resolved 
on SDS-PAGE and the gel was fluorographed. Results were q u a n t i t a t i v e l y 
evaluated by densitometry. 
t r a n s l o c a t i o n process have been unravelled. F i r s t of a l l , the membrane 
traversing step does not depend on nor i s i t o b l i g a t o r i l y coupled to 
p r o t e o l y t i c processing (11). Secondly, the translocation appears to occur at 
s i t e s of contact between inner and outer membrane. Translocation intermediates 
of the ß-subunit of FQF^-ATPase and of cytochrome c^ have been 
observed, which are accessible from both the cytoplasmic and the matrix side of 
the membranes (4). These intermediates were observed when transfer in vitro 
of precursor proteins into mitochondria was carried out at low temperature 
(7°C). They could also be observed by coupling the precursor to i t s antibody 
p r i o r to import and allow the complex to react with mitochondria (Fig.5). The 
comp lex between antibody and precursor i s only p a r t i a l l y imported even at room 
temperature. The orientation of these intermediates i s such that the amino 
terminus i s located in the matrix and thus can be cleaved by processing 
peptidase. The major part of the Polypeptide chain remains in the cytoplasm and 
therefore i s accessible to externally added protease. Interestingly the 
requirerr.ent of a membrane potential extends only to the formation of such a 
394 
transmembrane orientated intermediate (4). The rest of the Polypeptide chain 
i s translocated even i n the absence of a membrane p o t e n t i a l . Thus the membrane 
potential may have a t r i g g e r i n g role in transmembrane movement of precursors. 
1 2 3 4 5 
A 
Fig. 5. Transport into mitochondria of F«ß precursor bound to its 
antibody. 
Import of the precursor to F.ß into i s o l a t e d mitochondria was car r i e d out 
with free precursor (A) or with precursor bound to i t s antibody (B). After 
incubation of the precursors with mitochondria, mitochondria were r e i s o l a t e d . 
F.ß was imrrunoprecipitated from the various reactions under the usual 
cAnditions (antibody + protein A-Sepharose) (A) or by j u s t adding protein 
A-Sepharose (B). The immunoprecipitates were resolved by SDS-PAGE and 
fluorographed. 
Lane 1: supernatant of reaction 2; lane 2: import into mitochondria; lane 3: 
binding to mitochondria in the absence of a membrane p o t e n t i a l ; lane 4: import 
into mitochondria and subsequent treatment with Proteinase K; lane 5: import 
into mitochondria, immunoprecipitation in the presence of an excess of antigen. 
p, precursor;" m, mature F<ß. 
DISCUSSION 
Two of the components involved in the assembly of mitochondrial proteins have 
been characterized in some d e t a i l . These are the processing peptidase (12,13) 
and the receptors f o r precursor proteins. The import receptors recognize the 
precursor proteins and Channel them to the mitochondria. I t has been shown that 
the aminoterminal part of the precursor i s responsible f o r the in t e r a c t i o n with 
the mitochondrial import machinery (14,15). The nature of the int e r a c t i o n 
between precursor and receptor remains i l l - d e f i n e d . 
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Another unresolved question i s : how do the precursors move from the receptor 
to a contact S i t e and which proteins are involved in forming these S i t e s . 
Possibly only the precursor and the receptor are required to form a contact 
S i t e thus enabling the precursor to reach the inner membrane or the matrix. 
Since at least one of the translocation intermediates appears to be stable 
during f r a c t i o n a t i o n of mitochondria e f f o r t s are being made to enrich and 
i s o l a t e these contact Sites (16). The i s o l a t i o n and characterisation of the 
proteins c o n s t i t u t i n g the transport machinery, would allow the reconstitution 
of import from isolated components and could lead to an understanding of the 
molecular basis of protein sorting and import by mitochondria. 
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